Published in Cardiovascular Device Liability Week, June 15th, 2008
"For each subject from the rlvs group (LVEF <= 40%) and the nsr group, a 24-hour ECG Holter monitoring was performed. The width of the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Device Liability Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.